ABSTRACT

Woman with BRCA1 gene mutation following bilateral breast cancer treatment who developed acute pancreatitis

We report on the case of a 70-year-old woman, a carrier of the BRCA1 gene mutation, following oncological treatment due to bilateral breast cancer who developed acute pancreatitis. We discuss malignant tumor – (including metastasis) – induced acute pancreatitis, the possibility of metastases to the pancreas secondary to other cancers and the genetic syndromes and mutations associated with an increased risk of pancreatic cancer.

KEYWORDS: acute pancreatitis, BRCA1 gene mutation, breast cancer, pancreatic cancer screening.

Piśmiennictwo

1. Kohler H, Lankisch PG. Acute pancreatitis and hyperamylasemia in pancreatic carcinoma. Pancreas 1987;2(1):117-9

2. Rosłowski M, Lipiński M, Dobosz M et al. Management of acute pancreatitis (AP)-Polish Pancreatic Club recommendations. Gastroenterology Rev 2016;11(2):65-72

3. Tenner S, Baillie J, DeWitt J et al. American College of Gastroenterology Guideline: Management of Acute Pancreatitis. Am J Gastroenterol 2013;108:1400-15

4. Yu M, Zheng L, Han D et al. Systemic chemotherapy in metastasis-induced acute pancreatitis with small cell lung cancer. Pancreas 2019;48(10):1303-6

5. Mullady DK, Slivka A. Acute pancreatitis secondary to metastatic lobular breast carcinoma: report of a case and review of the literature. Pancreas 2007;35(2):194-6

6. Chen YG, Huang TY, Hsieh TY et al. Acute pancreatitis due to hypercalcemia related to bone metastasis from breast cancer. QJM 2013;106(4):367-9

7. Bednar F. Scheiman JM, McKenna BJ et al. Breast cancer metastases to the pancreas. J Gastrointestinal Surg 2013;17:1826-31

8. Trantopoulou C, Kolliakou E, Karoumpalis I et al. Metastatic disease to the pancreas: an imaging challenge. Insight into Imaging 2012;3(2):165-72

9. Pilarski A. The role of BRCA testing in hereditary pancreatic and prostate cancer families. ASCO Educational Book 2019, asco.org/ebook

10. Lo W, Morris MC, Ahmad SA et al. Screening patients at high risk for pancreatic cancer – Is it time for a paradigm shift? J Surg Oncol 2019;120:851-7

11. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Genetic/Familiar High-Risk Assessment: Breast and Ovarian (version 2.2019) 2019

12. Stoffel EM, McKernin SE, Brand R et al. Evaluating susceptibility to pancreatic cancer: ASCO Provisional Clinical Opinion. J Clin Oncol 2019;37:153-64

13. Syngal S, Brand RE, Church JM et al. American College of Gastroenterology. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 2015;110:223-62

Do góry